GSK plc (FRA:GS71)

Germany flag Germany · Delayed Price · Currency is EUR
16.47
+0.04 (0.24%)
At close: Jun 26, 2025, 10:00 PM CET
-12.81%
Market Cap 66.27B
Revenue (ttm) 37.69B
Net Income (ttm) 3.77B
Shares Out n/a
EPS (ttm) 0.91
PE Ratio 17.58
Forward PE 8.11
Dividend 0.74 (4.47%)
Ex-Dividend Date May 15, 2025
Volume 193,529
Average Volume 651,693
Open 16.49
Previous Close 16.43
Day's Range 16.40 - 16.55
52-Week Range 14.49 - 19.97
Beta n/a
RSI 36.32
Earnings Date Jul 28, 2025

About GSK plc

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer. It a... [Read more]

Industry Pharmaceutical Preparations
Founded 1715
Employees 68,629
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol GS71
Full Company Profile

Financial Performance

In 2024, GSK plc's revenue was 31.38 billion, an increase of 3.46% compared to the previous year's 30.33 billion. Earnings were 2.58 billion, a decrease of -47.75%.

Financial numbers in GBP Financial Statements

News

There is no news available yet.